Dr. Subramanian Murali

National & International Awards:

• GCRI Award for Outstanding Academic Achievements (2005)

Recognitions & Honours:

• Recognised for numerous publications in leading national and international journals.
• Esteemed academician and trainer for medical students.

Published Papers in Medical Journals:

• Unusual Case of Pulmonary and Hepatic Metastases of Mandibular Ameloblastoma. Indian Journal Of Medical & Paediatric Oncology, Vol. 28, No 3 (2007).
• Embryonal Rhabdomyosarcoma of Chest wall: a case report and review of literature. Indian Journal of Pathology and Microbiology, 51(2) (April-June 2008).
• Rituximab induced Subacute Interstitial Pneumonitis: A case report and review of literature. Journal of Cancer Research and Therapeutics, Vol 6 Issue (July – Sept 2010).
• Membranoproliferative Glomerulonephritis Secondary to Chronic Myeloid Leukaemia. Saudi Journal of Kidney Disease and Transplantation, 21(4), 738-741 (2010).
• A Rare case of Papillary Carcinoma of Choroid Plexus: Its management and review of literature. Indian Journal of Medical and Paediatric Oncology, Vol 32 Issue 2 (April – June 2011).
• The technique of Intraperitoneal Chemotherapy using Veress needle in patients with Ovarian Cancer. International Journal of Gynaecological Cancer, Vol 2, number 8 (November 2011).
• Feasibility of concurrent weekly Paclitaxel and Radiotherapy in Node-Positive Breast Cancer: An experience from Indian Journal of Clinical Oncology. Breast Cancer Symposium - Vol 30, No 27 Supplement (September 20 supplement), 2012: 201© 2012 American Society of Clinical Oncology (2012).
• Relapsed Hodgkin's Lymphoma presenting as an isolated ulcerative lesion of the base of tongue. Indian Journal of Haematology and Blood Transfusion, 30, 349-352 (2014).
• Unusual Aetiology of Secondary Thyrotoxicosis and its presentation. South Asian Journal of Cancer, Vol: 4 | Issue Number: 1 | Page: 46-47 (2015).
• Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature. Lymphoma, Volume 2014 (2014), Article ID 160421, 6 pages (2014).
• Incidence of Kirsten-ras gene mutation and its association with Clinical and Pathological factors in Colorectal Carcinoma: Single Institute Retrospective Experience. Annals of Oncology, Vol 25 Issue supplement 2 pp ii65 (poster presentation).
• Imatinib induced Pemphigus Foliaceus in Patients with GIST. Current Medical Issues, 18, 245-7 (2020).

Notable Cases Handled:

• Pioneered and successfully managed numerous patients through the first dedicated Day Care Chemo Infusion Centres in Bangalore.
• Successfully treated a wide array of solid tumours and haematological malignancies with systemic therapies, offering hope and improved quality of life.
• Expertly performed complex procedures like intrathecal and intraperitoneal chemotherapies for challenging cancer cases.

Patient Testimonials:

• “Dr. Murali is truly a lifesaver. His calm and compassionate approach made my chemotherapy journey much more bearable. He's not just a doctor, but a true guide in the fight against cancer.” - R. Kapoor
• “I was diagnosed with a rare haematological malignancy, and Dr. Murali's expertise in targeted therapy was exceptional. He explained everything clearly and gave me immense confidence throughout my treatment. I highly recommend him as a top medical oncologist in Bangalore.” - S. Devi
• “The convenience of the Day Care Chemo Centre, set up by Dr. Murali, was a blessing. His personalised care and deep knowledge in medical oncology are truly outstanding. He ensured I received the best possible treatment with minimal disruption to my daily life.” - A. Joseph

Patient-Centred Care: Dr. Subramanian Murali's philosophy centres on providing holistic, patient-focused cancer care. He believes in empowering patients with knowledge about their condition and treatment options, ensuring they are active participants in their care journey. His approachable and understanding demeanour fosters a supportive environment, prioritising both the efficacy of treatment and the patient's quality of life. He strives to offer hope and ensure comfort even in challenging cases.

Technology & Innovation: Dr. Murali is at the forefront of adopting advanced systemic therapies, including immunotherapy and targeted therapy, for managing diverse cancer types. His instrumental role in establishing dedicated Day Care Chemo Infusion Centres highlights his commitment to innovative healthcare delivery models that enhance patient convenience and access to cutting-edge treatments for cancer care in India. His extensive research further underscores his dedication to evidence-based, innovative oncology.

Note: These are estimated costs and may vary significantly based on the specific cancer type, stage, type and number of drugs used, duration of treatment, hospital stay, and supportive care requirements.

For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support: The Cancer Rounds team typically offers comprehensive support for international patients, including language services to ensure clear and effective communication throughout their treatment journey.

Visa & Travel Assistance: The Cancer Rounds team assists with various aspects of international patient travel, including visa processes, flight bookings, airport transfers, and arranging suitable accommodation in Bangalore.

Pre-treatment Virtual Consultations: Telemedicine capabilities are readily available for international patients to have initial consultations, undergo medical record reviews, and obtain second opinions from Dr. Subramanian Murali before travelling to India for their treatment.